BHVN vs BLTE

Biohaven Ltd. vs Belite Bio, Inc — Valuation Comparison 2026

BHVN

Biotechnology
Biohaven Ltd.
Quality
3.8
out of 10
Value Trap
30
LOW
Price
$10.24
Last close
Models
6/13
Active
VS

BLTE

Biotechnology
Belite Bio, Inc
Quality
4.7
out of 10
Value Trap
24
SAFE
Price
$148.00
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType BHVN Fair ValueBHVN Upside BLTE Fair ValueBLTE Upside
Bayesian DCF Intrinsic $2.84 -72.3% $49.41 -66.6%
Earnings Power Value Intrinsic $77.24 -52.1%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.20 -78.6% $14.93 -89.9%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BHVN vs BLTE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BHVN vs BLTE — Which Stock Is More Undervalued?

BLTE scores higher with a 4.7/10 quality rating vs BHVN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Biohaven Ltd. (BHVN) and Belite Bio, Inc (BLTE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BHVN currently trades at $10.24 with a QOC of 3.8/10, while BLTE trades at $148.00 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).